Mayo Clinic collaborates on new drug study showing improved survival for early breast cancer
October 23, 2025
October 23, 2025
ROCHESTER, Minnesota, Oct. 23 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
Mayo Clinic collaborates on new drug study showing improved survival for early breast cancer
*
ROCHESTER, Minn. Mayo Clinic researchers collaborated on a new study showing that the drug abemaciclib improves survival for people with high-risk, early-stage breast cancer.
In the phase 3 monarchE trial, two years of abemac . . .
* * *
Mayo Clinic collaborates on new drug study showing improved survival for early breast cancer
*
ROCHESTER, Minn. Mayo Clinic researchers collaborated on a new study showing that the drug abemaciclib improves survival for people with high-risk, early-stage breast cancer.
In the phase 3 monarchE trial, two years of abemac . . .
